Difference between revisions of "Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5 (Q9840)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 31, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English) | ||
| Property / title: Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hoffman LM, et al. Childs Nerv. Syst. (2015) cited as Ref 577 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Hoffman LM
0 references
2015
0 references
Childs Nerv. Syst.
0 references
31
0 references
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study (English)
0 references
